ProCE Banner Activity

How I Treat Older Adult Patients With MDS in My Practice

Clinical Thought
Older adult patients with comorbidities are a particular challenge for physicians who treat MDS. In this commentary, I describe why MDS in this population is hard to treat and discuss how I approach these patients in my own practice.

Released: August 26, 2021

Expiration: August 25, 2022

No longer available for credit.

Share

Faculty

Jamile Shammo

Jamile Shammo, MD, FASCP, FACP

Professor of Medicine and Pathology
Division of Hematology, Oncology, and Stem Cell Transplant
Director, MDS/MPN/Aplastic Anemia Program 
Rush University Medical Center
Chicago, Illinois

Provided by

Provided by Rush University Medical Center in partnership with Clinical Care Options, LLC, and the MDS Foundation.
ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Partners

MDS Foundation

ProCE Banner

Faculty Disclosure

Primary Author

Jamile Shammo, MD, FASCP, FACP

Professor of Medicine and Pathology
Division of Hematology, Oncology, and Stem Cell Transplant
Director, MDS/MPN/Aplastic Anemia Program 
Rush University Medical Center
Chicago, Illinois

Jamile Shammo, MD, FASCP, FACP, has disclosed that she has received research grants paid to her institution from AbbVie, Alexion, AstraZeneca, Bristol-Myers Squibb, CTI, Incyte, Kartos, Novartis, and Stemline; has received consulting fees from Alexion, Apellis, Bristol-Myers Squibb, Incyte, Novartis, Sanofi, and Takeda; has served on speaker bureaus for Alexion, Bristol-Myers Squibb, Incyte, and Sanofi; and has ownership interest in AbbVie, Baxter, and Takeda.